fig2

Signaling pathways downstream to receptor tyrosine kinases: targets for cancer treatment

Figure 2. Her2 signaling: HER2 is a member of the HER/EGFR family of RTKs. HER2 signaling has important roles in regulating normal cell function. However, its dysregulation is often implicated in cancer. HER2 can homodimerize with itself or heterodimerize with the other members of the HER family. Overexpression of HER2 can lead to the overactivation of the MAPK/ERK and PI3K/AKT/mTOR pathways, leading to uncontrolled cell growth and evasion of apoptosis. HER: human epidermal growth factor receptor; EGFR: epidermal growth factor receptor; RTK: receptor tyrosine kinase; MAPK: mitogen-activated protein kinase; ERK: extracellular signal-regulated kinases; PI3K: phosphoinositide 3-kinase; AKT: protein kinase B; mTOR: mammalian target of rapamycin

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/